News

16 March 2017

News

Oxford University to launch multimillion-dollar medical marijuana research program

SOURCE: CNBC

Oxford University will be at the forefront of a multimillion-pound research program, which hopes to help develop new therapies for acute and chronic conditions by examining the effects of medical cannabis.

The oldest university in England will be teaming up with private equity company, Kingsley Capital Partners who will provide up to £10 million ($12.36 million) in initial investment, which will be funded through its new biopharmaceutical firm Oxford Cannabinoid Technologies (OCT).

Read the full article


News

  • 09 August 2018

    High life: the start-up hoping to unlock the secrets of medical cannabis

    SOURCE: EVENING STANDARD

  • 28 June 2018

    OXFORD CANNABINOID TECHNOLOGIES GOES GLOBAL AS IT ANNOUNCES CLOSE OF SERIES A FUNDRAISING ROUND AND MANAGEMENT TEAM LINE-UP

    SOURCE: OCT PRESS RELEASE

  • 01 June 2017

    Embracing the medical potential of cannabinoids

    SOURCE: THE MEDICINE MAKER

  • 01 June 2017

    Smashing the stigma with science

    SOURCE: THE MEDICINE MAKER

  • 16 March 2017

    Oxford University launches £10m research project into medical marijuana

    SOURCE: EVENING STANDARD

  • 16 March 2017

    Oxford University launches £10m marijuana research programme

    SOURCE: BBC

  • 16 March 2017

    Oxford University to launch multimillion-dollar medical marijuana research program

    SOURCE: CNBC

  • 16 March 2017

    Oxford University to launch study on medical benefits of marijuana

    SOURCE: THE TELEGRAPH

  • 15 March 2017

    The University of Oxford and Kingsley Capital Partners announce ground breaking Cannabinoid Biomedicine Research Programme

    SOURCE: OCT PRESS RELEASE

Follow us on social media